155 related articles for article (PubMed ID: 37309394)
21. Dual combination therapy versus long-acting bronchodilators alone for chronic obstructive pulmonary disease (COPD): a systematic review and network meta-analysis.
Oba Y; Keeney E; Ghatehorde N; Dias S
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012620. PubMed ID: 30521694
[TBL] [Abstract][Full Text] [Related]
22. Single-Inhaler Triple versus Dual Bronchodilator Therapy in COPD: Real-World Comparative Effectiveness and Safety.
Suissa S; Dell'Aniello S; Ernst P
Int J Chron Obstruct Pulmon Dis; 2022; 17():1975-1986. PubMed ID: 36065315
[TBL] [Abstract][Full Text] [Related]
23. Prescribing pathways to triple therapy in patients with chronic obstructive pulmonary disease in the United States.
Schabert V; Shah S; Holmgren U; Cabrera C
Ther Adv Respir Dis; 2021; 15():17534666211001018. PubMed ID: 33866875
[TBL] [Abstract][Full Text] [Related]
24. Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD.
Lipson DA; Barnhart F; Brealey N; Brooks J; Criner GJ; Day NC; Dransfield MT; Halpin DMG; Han MK; Jones CE; Kilbride S; Lange P; Lomas DA; Martinez FJ; Singh D; Tabberer M; Wise RA; Pascoe SJ;
N Engl J Med; 2018 May; 378(18):1671-1680. PubMed ID: 29668352
[TBL] [Abstract][Full Text] [Related]
25. Effectiveness and Safety of COPD Maintenance Therapy with Tiotropium/Olodaterol versus LABA/ICS in a US Claims Database.
Quint JK; Montonen J; Esposito DB; He X; Koerner L; Wallace L; de la Hoz A; Miravitlles M
Adv Ther; 2021 May; 38(5):2249-2270. PubMed ID: 33721209
[TBL] [Abstract][Full Text] [Related]
26. Telehealth interventions: remote monitoring and consultations for people with chronic obstructive pulmonary disease (COPD).
Janjua S; Carter D; Threapleton CJ; Prigmore S; Disler RT
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013196. PubMed ID: 34693988
[TBL] [Abstract][Full Text] [Related]
27. Economic impact of delaying initiation with multiple-inhaler maintenance triple therapy in Spanish patients with chronic obstructive pulmonary disease.
Sicras Mainar A; Huerta A; Navarro Artieda R; Monsó E; Landis SH; Ismaila AS
Int J Chron Obstruct Pulmon Dis; 2019; 14():2121-2129. PubMed ID: 31571848
[TBL] [Abstract][Full Text] [Related]
28. Impact of long-acting bronchodilators and exposure to inhaled corticosteroids on mortality in COPD: a real-life retrospective cohort study.
Manoharan A; Short PM; Anderson WJ; Lipworth BJ
Lung; 2014 Oct; 192(5):649-52. PubMed ID: 24952426
[TBL] [Abstract][Full Text] [Related]
29. The effects of single inhaler triple therapy vs single inhaler dual therapy or separate triple therapy for the management of chronic obstructive pulmonary disease: a systematic review and meta-analysis of randomized controlled trials.
Lai CC; Chen CH; Lin CYH; Wang CY; Wang YH
Int J Chron Obstruct Pulmon Dis; 2019; 14():1539-1548. PubMed ID: 31371939
[TBL] [Abstract][Full Text] [Related]
30. Treatment patterns and cost of exacerbations in patients with chronic obstructive pulmonary disease using multiple inhaler triple therapy in South Korea.
Lee CH; Kim MS; Yeo SH; Rhee CK; Park HW; Yang BR; Lee J; Cho EY; Xu X; Navarro Rojas AA; Shantakumar S; Milea D; Choi NK
Respir Res; 2022 Sep; 23(1):231. PubMed ID: 36064539
[TBL] [Abstract][Full Text] [Related]
31. Prescription Pathways from Initial Medication Use to Triple Therapy in Older COPD Patients: A Real-World Population Study.
Jiang L; Kendzerska T; Aaron SD; Stukel TA; Stanbrook MB; Tan W; Pequeno P; Gershon AS
COPD; 2022; 19(1):315-323. PubMed ID: 35946353
[TBL] [Abstract][Full Text] [Related]
32. Real-world effectiveness of early intervention with fixed-dose tiotropium/olodaterol vs tiotropium in Japanese patients with COPD: a high-dimensional propensity score-matched cohort analysis.
Muro S; Suzuki M; Nakamura S; Wang JR; Garry EM; Sakamoto W; de Souza S
Respir Res; 2021 Jun; 22(1):180. PubMed ID: 34140019
[TBL] [Abstract][Full Text] [Related]
33. Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial.
Papi A; Vestbo J; Fabbri L; Corradi M; Prunier H; Cohuet G; Guasconi A; Montagna I; Vezzoli S; Petruzzelli S; Scuri M; Roche N; Singh D
Lancet; 2018 Mar; 391(10125):1076-1084. PubMed ID: 29429593
[TBL] [Abstract][Full Text] [Related]
34. A retrospective study to assess clinical characteristics and time to initiation of open-triple therapy among patients with chronic obstructive pulmonary disease, newly established on long-acting mono- or combination therapy.
Mapel D; Laliberté F; Roberts MH; Sama SR; Sundaresan D; Pilon D; Lefebvre P; Duh MS; Patel J
Int J Chron Obstruct Pulmon Dis; 2017; 12():1825-1836. PubMed ID: 28684905
[TBL] [Abstract][Full Text] [Related]
35. Predicting response to benralizumab in chronic obstructive pulmonary disease: analyses of GALATHEA and TERRANOVA studies.
Criner GJ; Celli BR; Singh D; Agusti A; Papi A; Jison M; Makulova N; Shih VH; Brooks L; Barker P; Martin UJ; Newbold P
Lancet Respir Med; 2020 Feb; 8(2):158-170. PubMed ID: 31575508
[TBL] [Abstract][Full Text] [Related]
36. Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).
Herath SC; Normansell R; Maisey S; Poole P
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD009764. PubMed ID: 30376188
[TBL] [Abstract][Full Text] [Related]
37. Chronic non-invasive ventilation for chronic obstructive pulmonary disease.
Raveling T; Vonk J; Struik FM; Goldstein R; Kerstjens HA; Wijkstra PJ; Duiverman ML
Cochrane Database Syst Rev; 2021 Aug; 8(8):CD002878. PubMed ID: 34368950
[TBL] [Abstract][Full Text] [Related]
38. Clinical Characteristics, Treatment Persistence, and Outcomes Among Patients With COPD Treated With Single- or Multiple-Inhaler Triple Therapy: A Retrospective Analysis in Spain.
Alcázar-Navarrete B; Jamart L; Sánchez-Covisa J; Juárez M; Graefenhain R; Sicras-Mainar A
Chest; 2022 Nov; 162(5):1017-1029. PubMed ID: 35787391
[TBL] [Abstract][Full Text] [Related]
39. A Real-World Analysis of Treatment Patterns and Clinical Characteristics Among Patients with COPD Who Initiated Multiple-Inhaler Triple Therapy in New Zealand.
Xu X; Milea D; Navarro Rojas AA; Braganza A; Holbrook T; Marett B; Young R; Scott RJ; Gribben B
Int J Chron Obstruct Pulmon Dis; 2021; 16():1835-1850. PubMed ID: 34177262
[TBL] [Abstract][Full Text] [Related]
40. GOLD 2017 treatment pathways in 'real life': An analysis of the DACCORD observational study.
Worth H; Buhl R; Criée CP; Kardos P; Lossi NS; Vogelmeier CF
Respir Med; 2017 Oct; 131():77-84. PubMed ID: 28947047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]